Compare OCGN & CCSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OCGN | CCSI |
|---|---|---|
| Founded | 2013 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 387.3M | 443.8M |
| IPO Year | N/A | N/A |
| Metric | OCGN | CCSI |
|---|---|---|
| Price | $1.60 | $22.09 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 2 |
| Target Price | $7.00 | ★ $33.50 |
| AVG Volume (30 Days) | ★ 6.2M | 161.3K |
| Earning Date | 03-04-2026 | 02-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 4.22 |
| Revenue | $5,370,000.00 | ★ $349,609,000.00 |
| Revenue This Year | $35.88 | $1.67 |
| Revenue Next Year | N/A | $0.97 |
| P/E Ratio | ★ N/A | $5.24 |
| Revenue Growth | ★ 14.26 | N/A |
| 52 Week Low | $0.52 | $17.84 |
| 52 Week High | $1.96 | $32.10 |
| Indicator | OCGN | CCSI |
|---|---|---|
| Relative Strength Index (RSI) | 51.41 | 47.37 |
| Support Level | $1.57 | $21.31 |
| Resistance Level | $1.70 | $22.13 |
| Average True Range (ATR) | 0.14 | 0.79 |
| MACD | -0.02 | 0.03 |
| Stochastic Oscillator | 22.45 | 51.89 |
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
Consensus Cloud Solutions Inc is a provider of secure information delivery services with a scalable Software-as-a-Service SaaS platform. It is engaged in fax cloud business. The Company operates in USA, Canada, Ireland, and Other. Geographically, it derives a maximum revenue from the United States. The company's communication and digital signature solutions enable customers to securely and cooperatively access, exchange and use information across organizational, regional, and national boundaries.